Literature DB >> 11749585

Three-dimensional quantitative structure-permeability relationship analysis for a series of inhibitors of rhinovirus replication.

S Ekins1, G L Durst, R E Stratford, D A Thorner, R Lewis, R J Loncharich, J H Wikel.   

Abstract

Multiple three-dimensional quantitative structure-activity relationship (3D-QSAR) approaches were applied to predicting passive Caco-2 permeability for a series of 28 inhibitors of rhinovirus replication. Catalyst, genetic function approximation (GFA) with MS-WHIM descriptors, CoMFA, and VolSurf were all used for generating 3D-quantitative structure permeability relationships utilizing a training set of 19 molecules. Each of these approaches was then compared using a test set of nine molecules not present in the training set. Statistical parameters for the test set predictions (r(2) and leave-one-out q(2)) were used to compare the models. It was found that the Catalyst pharmacophore model was the most predictive (test set of predicted versus observed permeability, r(2) = 0.94). This model consisted of a hydrogen bond acceptor, hydrogen bond donor, and ring aromatic feature with a training set correlation of r(2) = 0.83. The CoMFA model consisted of three components with an r(2) value of 0.96 and produced good predictions for the test set (r(2) = 0.84). VolSurf resulted in an r(2) value of 0.76 and good predictions for the test set (r(2) = 0.83). Test set predictions with GFA/WHIM descriptors (r(2) = 0.46) were inferior when compared with the Catalyst, CoMFA, and VolSurf model predictions in this evaluation. In summary it would appear that the 3D techniques have considerable value in predicting passive permeability for a congeneric series of molecules, representing a valuable asset for drug discovery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11749585     DOI: 10.1021/ci010330i

Source DB:  PubMed          Journal:  J Chem Inf Comput Sci        ISSN: 0095-2338


  12 in total

1.  Predicting drug pharmacokinetic properties using molecular interaction fields and SIMCA.

Authors:  Philippa R N Wolohan; Robert D Clark
Journal:  J Comput Aided Mol Des       Date:  2003-01       Impact factor: 3.686

Review 2.  Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.

Authors:  Anna Egorova; Sean Ekins; Michaela Schmidtke; Vadim Makarov
Journal:  Eur J Med Chem       Date:  2019-06-11       Impact factor: 6.514

3.  An atomistic model of passive membrane permeability: application to a series of FDA approved drugs.

Authors:  Chakrapani Kalyanaraman; Matthew P Jacobson
Journal:  J Comput Aided Mol Des       Date:  2007-11-08       Impact factor: 3.686

Review 4.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

5.  Towards a new age of virtual ADME/TOX and multidimensional drug discovery.

Authors:  Sean Ekins; Bruno Boulanger; Peter W Swaan; Maggie A Z Hupcey
Journal:  J Comput Aided Mol Des       Date:  2002 May-Jun       Impact factor: 3.686

6.  Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements.

Authors:  Caroline A Larregieu; Leslie Z Benet
Journal:  AAPS J       Date:  2013-01-24       Impact factor: 4.009

7.  Testing physical models of passive membrane permeation.

Authors:  Siegfried S F Leung; Jona Mijalkovic; Kenneth Borrelli; Matthew P Jacobson
Journal:  J Chem Inf Model       Date:  2012-05-24       Impact factor: 4.956

8.  Predicting and improving the membrane permeability of peptidic small molecules.

Authors:  Salma B Rafi; Brian R Hearn; Punitha Vedantham; Matthew P Jacobson; Adam R Renslo
Journal:  J Med Chem       Date:  2012-03-20       Impact factor: 7.446

9.  Chemical substituent effect on pyridine permeability and mechanistic insight from computational molecular descriptors.

Authors:  I-Jen Chen; Rajneesh Taneja; Daxu Yin; Paul R Seo; David Young; Alexander D MacKerell; James E Polli
Journal:  Mol Pharm       Date:  2006 Nov-Dec       Impact factor: 4.939

Review 10.  Towards a new age of virtual ADME/TOX and multidimensional drug discovery.

Authors:  Sean Ekins; Bruno Boulanger; Peter W Swaan; Maggie A Z Hupcey
Journal:  Mol Divers       Date:  2002       Impact factor: 2.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.